Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE48.5100
- TODAY'S CHANGE (%)0.3400 (0.7058%)
- Bid / Lots48.4600/ 1
- Ask / Lots48.6200/ 4
- Open / Previous Close48.3900 / 48.1700
- Day Range
- 52 Week Range
- Volume423,110
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 8621 | 48.3 |
| 09:34 ET | 500 | 48.02 |
| 09:36 ET | 615 | 47.99 |
| 09:38 ET | 1350 | 47.995 |
| 09:39 ET | 4662 | 48.799 |
| 09:41 ET | 57389 | 48.5826 |
| 09:43 ET | 8425 | 48.585 |
| 09:45 ET | 4000 | 49.1243 |
| 09:48 ET | 2050 | 49.68 |
| 09:50 ET | 10255 | 49.42 |
| 09:52 ET | 3100 | 49.3728 |
| 09:54 ET | 5451 | 49.015 |
| 09:56 ET | 5540 | 49.17 |
| 09:57 ET | 205 | 49.0463 |
| 09:59 ET | 2695 | 49.0208 |
| 10:01 ET | 2903 | 48.76 |
| 10:03 ET | 1911 | 48.8727 |
| 10:06 ET | 3300 | 48.28 |
| 10:08 ET | 400 | 48.2 |
| 10:10 ET | 4105 | 48.2 |
| 10:12 ET | 2662 | 48.15 |
| 10:14 ET | 500 | 48 |
| 10:15 ET | 400 | 48.01 |
| 10:17 ET | 1200 | 47.9999 |
| 10:19 ET | 4336 | 47.705 |
| 10:21 ET | 2380 | 47.9921 |
| 10:24 ET | 110 | 47.7001 |
| 10:26 ET | 100 | 47.815 |
| 10:28 ET | 450 | 47.79 |
| 10:30 ET | 3500 | 47.88 |
| 10:32 ET | 6280 | 48.04 |
| 10:33 ET | 100 | 48.15 |
| 10:35 ET | 3176 | 47.825 |
| 10:37 ET | 7435 | 47.79 |
| 10:39 ET | 325 | 47.725 |
| 10:42 ET | 1300 | 47.51 |
| 10:44 ET | 2741 | 47.645 |
| 10:46 ET | 300 | 47.62 |
| 10:48 ET | 1000 | 47.75 |
| 10:50 ET | 200 | 47.76 |
| 10:51 ET | 900 | 47.71 |
| 10:53 ET | 793 | 47.675 |
| 10:55 ET | 1698 | 47.52 |
| 10:57 ET | 807 | 47.605 |
| 11:00 ET | 1000 | 47.52 |
| 11:02 ET | 1300 | 47.52 |
| 11:04 ET | 4124 | 47.5 |
| 11:06 ET | 900 | 47.55 |
| 11:08 ET | 2800 | 47.64 |
| 11:09 ET | 2825 | 47.43 |
| 11:11 ET | 300 | 47.455 |
| 11:13 ET | 14012 | 47.22 |
| 11:15 ET | 600 | 47.18 |
| 11:18 ET | 5453 | 47.39 |
| 11:20 ET | 3794 | 47.57 |
| 11:22 ET | 525 | 47.6 |
| 11:24 ET | 100 | 47.63 |
| 11:26 ET | 625 | 47.605 |
| 11:27 ET | 400 | 47.6785 |
| 11:29 ET | 650 | 47.55 |
| 11:31 ET | 800 | 47.5 |
| 11:33 ET | 1500 | 47.43 |
| 11:36 ET | 400 | 47.465 |
| 11:38 ET | 700 | 47.44 |
| 11:40 ET | 1782 | 47.64 |
| 11:42 ET | 500 | 47.69 |
| 11:44 ET | 900 | 47.7398 |
| 11:45 ET | 2257 | 47.89 |
| 11:47 ET | 300 | 47.9 |
| 11:49 ET | 300 | 47.8319 |
| 11:51 ET | 1100 | 47.81 |
| 11:54 ET | 18092 | 47.595 |
| 11:56 ET | 625 | 47.53 |
| 11:58 ET | 100 | 47.54 |
| 12:00 ET | 17200 | 47.475 |
| 12:02 ET | 1755 | 47.475 |
| 12:03 ET | 1324 | 47.6 |
| 12:05 ET | 500 | 47.6 |
| 12:07 ET | 2758 | 47.505 |
| 12:09 ET | 400 | 47.57 |
| 12:12 ET | 1827 | 47.76 |
| 12:16 ET | 400 | 47.8 |
| 12:18 ET | 1000 | 47.79 |
| 12:20 ET | 705 | 47.73 |
| 12:21 ET | 400 | 47.73 |
| 12:23 ET | 910 | 47.6824 |
| 12:25 ET | 3223 | 47.6043 |
| 12:27 ET | 2506 | 47.6301 |
| 12:30 ET | 200 | 47.71 |
| 12:32 ET | 200 | 47.64 |
| 12:34 ET | 100 | 47.685 |
| 12:36 ET | 903 | 47.735 |
| 12:38 ET | 1600 | 47.53 |
| 12:39 ET | 3114 | 47.655 |
| 12:41 ET | 500 | 47.68 |
| 12:43 ET | 740 | 47.8362 |
| 12:45 ET | 1254 | 47.66 |
| 12:48 ET | 799 | 47.62 |
| 12:50 ET | 3102 | 47.75 |
| 12:52 ET | 1700 | 47.7025 |
| 12:54 ET | 900 | 47.84 |
| 12:56 ET | 1400 | 47.8237 |
| 12:57 ET | 1399 | 47.77 |
| 12:59 ET | 2791 | 47.925 |
| 01:01 ET | 100 | 47.92 |
| 01:03 ET | 400 | 47.86 |
| 01:06 ET | 1401 | 48.12 |
| 01:08 ET | 1218 | 48.11 |
| 01:10 ET | 1400 | 48.1 |
| 01:12 ET | 600 | 48.085 |
| 01:14 ET | 1604 | 48.17 |
| 01:15 ET | 100 | 48.22 |
| 01:17 ET | 1164 | 48.34 |
| 01:19 ET | 1085 | 48.44 |
| 01:21 ET | 425 | 48.5 |
| 01:24 ET | 883 | 48.5 |
| 01:26 ET | 1300 | 48.46 |
| 01:28 ET | 1602 | 48.335 |
| 01:30 ET | 500 | 48.44 |
| 01:32 ET | 2000 | 48.44 |
| 01:33 ET | 1755 | 48.52 |
| 01:35 ET | 800 | 48.58 |
| 01:37 ET | 100 | 48.61 |
| 01:39 ET | 603 | 48.565 |
| 01:42 ET | 911 | 48.5 |
| 01:44 ET | 500 | 48.48 |
| 01:46 ET | 2400 | 48.67 |
| 01:48 ET | 2446 | 48.86 |
| 01:50 ET | 2000 | 48.88 |
| 01:51 ET | 6919 | 48.67 |
| 01:53 ET | 790 | 48.48 |
| 01:55 ET | 875 | 48.62 |
| 01:57 ET | 1723 | 48.5 |
| 02:00 ET | 355 | 48.49 |
| 02:02 ET | 1601 | 48.54 |
| 02:04 ET | 1152 | 48.49 |
| 02:06 ET | 1800 | 48.48 |
| 02:08 ET | 2200 | 48.62 |
| 02:09 ET | 408 | 48.63 |
| 02:11 ET | 6766 | 48.55 |
| 02:13 ET | 100 | 48.5601 |
| 02:15 ET | 700 | 48.46 |
Today
Jun 7, 2024
Press Release: Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares, from 4:05PM ET on Friday Jun 07, 2024 by Dow Jones
4:05PM ET on Friday Jun 07, 2024 by Dow JonesStructure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares, from 4:05PM ET on Friday Jun 07, 2024 by Dow Jones
4:05PM ET on Friday Jun 07, 2024 by Dow JonesDJ Structure Therapeutics Is Maintained at Outperform by BMO Capital, from 10:47AM ET on Friday Jun 07, 2024 by Dow Jones
10:47AM ET on Friday Jun 07, 2024 by Dow Jones
Jun 5, 2024
*DJ Structure Therapeutics' 9.1 Million-ADS Offering Prices at $52.50 an ADS >GPCR, from 7:54PM ET on Wednesday Jun 05, 2024 by Dow Jones
7:54PM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 2.7B | -20.9x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.6x | --- |
MoonLake Immunotherapeutics | 2.6B | -54.2x | --- |
Geron Corp | 2.9B | -13.6x | --- |
SpringWorks Therapeutics Inc | 2.9B | -7.1x | --- |
Biohaven Ltd | 3.0B | -4.9x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Chief Executive Officer, Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -20.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
